In vitro and in vivo efficacy of Tecovirimat against a recently emerged 2022 Monkeypox virus isolate

Monkeypox 2022 outbreak: an update

(2022) Thirumalaisamy P. Velavan et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Making sense of monkeypox death rates

(2022) Lauren Vogel   CANADIAN MEDICAL ASSOCIATION JOURNAL

Monkeypox as a PHEIC: implications for global health governance

(2022) Clare Wenham et al.   LANCET

Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus

(2022) Joana Isidro et al.   NATURE MEDICINE

Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerations

(2022) Adam Sherwat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Monkeypox vaccination plans take shape amid questions

(2022) Kai Kupferschmidt   SCIENCE

Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection

(2022) Angel N. Desai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Can a smallpox drug treat monkeypox? Here’s what scientists know

(2022) Max Kozlov   NATURE

Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox

(2019) Kirk M Chan-Tack et al.   LANCET INFECTIOUS DISEASES

Identification of Wild-Derived Inbred Mouse Strains Highly Susceptible to Monkeypox Virus Infection for Use as Small Animal Models

(2010) J. L. Americo et al.   JOURNAL OF VIROLOGY

In Vitro Efficacy of ST246 against Smallpox and Monkeypox

(2008) S. K. Smith et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY